MP02-Farmacología Cardiovascular
Medicina de Precisión / IBS-MP02
Nuestras líneas de investigación tienen como objetivos generales: estudiar el papel del sistema inmune en la disfunción endotelial en hipertensión, buscar estrategias de modulación de la flora intestinal y su impacto integral en el control de la presión arterial. En ambos casos colaboramos con el Hospital Universitario Virgen de la Nieves de Granada y con empresas como Biosearch SA y con el Centro Tecnológico de Investigación y Desarrollo del Alimento Funcional (CIDAF).
MARTA TORAL JIMENEZ
JAVIER MOLEON MOYA
CRISTINA GONZALEZ CORREA
JUAN MANUEL DUARTE PEREZ
MANUEL GOMEZ GUZMAN
ROSARIO JIMENEZ MOLEON
MIGUEL ROMERO PEREZ
MANUEL SANCHEZ SANTOS
Community pharmacy is the key to improving vitamin D levels
EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2023;
Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation
PHARMACOLOGICAL RESEARCH, 2023;
FI:9,3; D1
Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study
GUT MICROBES, 2023;
FI:12,2; D1
Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats
BIOMEDICINE & PHARMACOTHERAPY, 2023;
FI:7,5; Q1
Probiotics and Prebiotics in Cardiovascular Diseases
NUTRIENTS, 2023;
FI:5,9; Q1
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022;
FI:7,088; D1
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022;
FI:7,088; D1
The Antioxidant Activity of Thymus serpyllum Extract Protects against the Inflammatory State and Modulates Gut Dysbiosis in Diet-Induced Obesity in Mice.
ANTIOXIDANTS, 2022;
FI:7,675; D1
The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome.
BIOMEDICINE & PHARMACOTHERAPY, 2022;
FI:7,419; D1
Trimethylamine N-Oxide Promotes Autoimmunity and a Loss of Vascular Function in Toll-like Receptor 7-Driven Lupus Mice
ANTIOXIDANTS, 2022;
FI:7,675; D1
Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus
BRITISH JOURNAL OF PHARMACOLOGY, 2021;
FI:8,74; D1
Gut Microbiota Has a Crucial Role in the Development of Hypertension and Vascular Dysfunction in Toll-like Receptor 7-Driven Lupus Autoimmunity
ANTIOXIDANTS, 2021;
FI:6,313; D1
Allium-Derived Compound Propyl Propane Thiosulfonate (PTSO) Attenuates Metabolic Alterations in Mice Fed a High-Fat Diet through Its Anti-Inflammatory and Prebiotic Properties
NUTRIENTS, 2021;
FI:5,719; Q1
Changes in Gut Microbiota Induced by Doxycycline Influence in Vascular Function and Development of Hypertension in DOCA-Salt Rats
NUTRIENTS, 2021;
FI:5,719; Q1
EVALUATION OF DOCETAXEL USE IN NON-SMALL CELL LUNG CANCER: REAL-WORLD HEALTH OUTCOMES
FARMACIA, 2021;
FI:1,433; Q4
Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects
BRITISH JOURNAL OF PHARMACOLOGY, 2020;
FI:7,73; D1
Antihypertensive Effects of Virgin Olive Oil (Unfiltered) Low Molecular Weight Peptides with ACE Inhibitory Activity in Spontaneously Hypertensive Rats
NUTRIENTS, 2020;
FI:4,546; Q1
Gut DYSBIOSIS and altered barrier function precedes the appearance of metabolic syndrome in a rat model of nutrient-induced catch-up growth
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2020;
FI:4,873; Q1
Impact of Nutrition on Pulmonary Arterial Hypertension
NUTRIENTS, 2020;
FI:4,546; Q1
Lactobacillus fermentumCECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus
FOOD & FUNCTION, 2020;
FI:4,171; Q1
Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats
ACTA PHYSIOLOGICA, 2019;
FI:5,868; D1
Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus
FASEB JOURNAL, 2019;
FI:5,391; D1
beta-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in Coq9(R239X) mice
EMBO MOLECULAR MEDICINE, 2019;
FI:10,624; D1
Protective Effects of Probiotic Consumption in Cardiovascular Disease in Systemic Lupus Erythematosus
NUTRIENTS, 2019;
FI:4,171; Q1
Cardiovascular Effects of Flavonoids
CURRENT MEDICINAL CHEMISTRY, 2019;
FI:3,894; Q1
Lactobacillus fermentum Improves Tacrolimus-Induced Hypertension by Restoring Vascular Redox State and Improving eNOS Coupling
MOLECULAR NUTRITION & FOOD RESEARCH, 2018;
FI:5,151; D1
The Probiotic Lactobacillus fermentum Prevents Dysbiosis and Vascular Oxidative Stress in Rats with Hypertension Induced by Chronic Nitric Oxide Blockade
MOLECULAR NUTRITION & FOOD RESEARCH, 2018;
FI:5,151; D1
Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome
SCIENTIFIC REPORTS, 2018;
FI:4,122; Q1
The Role of Nrf2 Signaling in PPAR beta/delta-Mediated Vascular Protection against Hyperglycemia-Induced Oxidative Stress
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018;
FI:4,936; Q2
Thiadiazoline- and Pyrazoline-Based Carboxamides and Carbothioamides: Synthesis and Inhibition against Nitric Oxide Synthase
JOURNAL OF CHEMISTRY, 2018;
FI:1,726; Q3
Activation of Peroxisome Proliferator Activator Receptor / Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus
HYPERTENSION, 2017;
FI:6,857; D1
CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome
EMBO MOLECULAR MEDICINE, 2017;
FI:9,249; D1
Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress
FASEB JOURNAL, 2017;
FI:5,498; D1
Protective vascular effects of quercitrin in acute TNBS-colitis in rats: the role of nitric oxide
FOOD & FUNCTION, 2017;
FI:3,247; Q1
Role of endoplasmic reticulum stress in the protective effects of PPAR beta/delta activation on endothelial dysfunction induced by plasma from patients with lupus
ARTHRITIS RESEARCH & THERAPY, 2017;
FI:4,121; Q1
Role of UCP2 in the protective effects of PPAR beta/delta activation on lipopolysaccharide-induced endothelial dysfunction
BIOCHEMICAL PHARMACOLOGY, 2016;
FI:5,091; D1
Effects of BM-573 on Endothelial Dependent Relaxation and Increased Blood Pressure at Early Stages of Atherosclerosis
PLOS ONE, 2016;
FI:3,057; Q1
Antihypertensive effects of oleuropein-enriched olive leaf extract in spontaneously hypertensive rats
FOOD & FUNCTION, 2016;
FI:2,686; Q1
Activation of PPAR beta/delta prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries
CLINICAL SCIENCE, 2016;
FI:5,016; Q1
Effects of Quercetin in a Rat Model of Hemorrhagic Traumatic Shock and Reperfusion
MOLECULES, 2016;
FI:2,465; Q2
Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats
MOLECULAR NUTRITION & FOOD RESEARCH, 2015;
FI:4,603; D1
Kv7 channels critically determine coronary artery reactivity: left-right differences and down-regulation by hyperglycaemia
CARDIOVASCULAR RESEARCH, 2015;
FI:5,94; D1
New Antihypertensive Drugs Under Development
CURRENT MEDICINAL CHEMISTRY, 2015;
FI:3,853; D1
Increased Klk9 Urinary Excretion Is Associated to Hypertension-Induced Cardiovascular Damage and Renal Alterations
MEDICINE, 2015;
FI:5,723; D1
Carnitine palmitoyltransferase-1 up-regulation by PPAR-beta/delta prevents lipid-induced endothelial dysfunction
CLINICAL SCIENCE, 2015;
FI:5,598; Q1
ESTUDIO DE LA IMPORTANCIA DE LA MICROBIOTA INTESTINAL EN LAS COMPLICACIONES CARDIOVASCULARES DURANTE LA MENOPAUSIA (I-MI-CAR-MEN)
Financiador: INSTITUTO DE SALUD CARLOS III - FEDER
Número de expediente: PI23/00734
Tiempo de ejecución: 01/01/2024 - 31/12/2026
IP: MANUEL GOMEZ GUZMAN
CONTRIBUCIÓN DEL METABOLITO DE LA MICROBIOTA INTESTINAL TRIMETILAMINA EN EL DESARROLLO DE DISFUNCIÓN VASCULAR EN PACIENTES CON LUPUS ERITEMATOSO SISTÉMICO
Financiador: INSTITUTO DE SALUD CARLOS III - FEDER
Número de expediente: PI22/01046
Tiempo de ejecución: 01/01/2023 - 31/12/2025
IP: ROSARIO JIMENEZ MOLEON
Mecanismos celulares y moleculares involucrados en los efectos protectores cardiovasculares de moduladores metabólicos en el lupus eritematoso sistémico
Financiador: UNIVERSIDAD DE GRANADA
Número de expediente: A-CTS-318-UGR20
Tiempo de ejecución: 01/07/2021 - 30/06/2023
IP: JUAN MANUEL DUARTE PEREZ
SUPLEMENTACION DIETETICA CON PROBIOTICOS, SISTEMA INMUNE E HIPERTENSION ARTERIAL
Financiador: MINISTERIO DE ECONOMIA Y COMPETITIVIDAD
Número de expediente: SAF2014-55523-R
Tiempo de ejecución: 01/01/2015 - 31/12/2017
IP: JUAN MANUEL DUARTE PEREZ